| 准分子激光原位角膜磨镶术相关干眼的药物治疗进展 |
| |
| 引用本文： | 黄辉,邹俊. 准分子激光原位角膜磨镶术相关干眼的药物治疗进展[J]. 世界临床药物, 2012, 33(1): 45-49 |
| |
| 作者姓名： | 黄辉 邹俊 |
| |
| 作者单位： | 上海交通大学附属第六人民医院眼科,上海,200233 |
| |
| 摘 要： | 干眼是准分子激光原位角膜磨镶术(LASIK)后最常见的并发症之一。术前患者存在的眼表疾病和干眼状态是增加或加重术后干眼发生率的主要因素。本文综述LASIK术后干眼的药物治疗进展。
|
| 关 键 词： | 准分子激光原位角膜磨镶术 干眼 药物治疗 |
Drug therapy for dry eye after Laser in situ keratomileusis |
| |
| HUANG Hui,ZOU Jun. Drug therapy for dry eye after Laser in situ keratomileusis[J]. WORLD CLINICAL DRUGS, 2012, 33(1): 45-49 |
| |
| Authors: | HUANG Hui ZOU Jun |
| |
| Affiliation: | (Department of Ophthalmology,Shanghai No.6 People’s Hospital,Shanghai Jiaotong University,Shanghai 200233,China) |
| |
| Abstract: | Dry eye is one of the most common complications after Laser in situ keratomileusis(LASIK).Preoperative inflammation and dry eye condition are major risk factors for severe dry eye after LASIK.This review describes the progress in drug therapy for dry eye after LASIK. |
| |
| Keywords: | Laser in situ keratomileusis dry eye drug therapy |
| 本文献已被 CNKI 万方数据 等数据库收录！ |
